human breast cancer cell line bt549 (ATCC)
Structured Review
Human Breast Cancer Cell Line Bt549, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 2975 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bt549+human+breast+cancer+cell+line/BT-549/pm41740339-52-16-42
Average 99 stars, based on 2975 article reviews
Images
Related Articles
Cell Culture:Article Title: Lactic acid inhibits the interaction between PD-L1 protein and PD-L1 antibody in the PD-1/PD-L1 blockade therapy-resistant tumor. Article Snippet: Received 20 June 2024; accepted 27 December 2024; https://doi.org/10.1016/j.ymthe.2024.12.044.. These authors contributed equally Correspondence: Seung-Oe Lim, Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, USA.. E-mail: limsoe@purdue.edu Immune checkpoint blockade therapy targeting the programmed death 1 (PD-1)/programmed death ligand 1 (PDL1) axis has shown remarkable clinical impact in multiple cancer types. Transfection:Article Title: Lactic acid inhibits the interaction between PD-L1 protein and PD-L1 antibody in the PD-1/PD-L1 blockade therapy-resistant tumor. Article Snippet: Received 20 June 2024; accepted 27 December 2024; https://doi.org/10.1016/j.ymthe.2024.12.044.. These authors contributed equally Correspondence: Seung-Oe Lim, Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, USA.. E-mail: limsoe@purdue.edu Immune checkpoint blockade therapy targeting the programmed death 1 (PD-1)/programmed death ligand 1 (PDL1) axis has shown remarkable clinical impact in multiple cancer types. |
